Gene · 10890
Papers1,621
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,621
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10. | Aging (Albany NY) | 2024 | 38364252 | PubTator, text mining | PubMed |
| VPS13C regulates phospho-Rab10-mediated lysosomal function in human dopaminergic neurons. | J Cell Biol | 2024 | 38358348 | PubTator, text mining | PubMed |
| Lysosomal stress drives the release of pathogenic α-synuclein from macrophage lineage cells via the LRRK2-Rab10 pathway. | iScience | 2024 | 38313055 | PubTator, text mining | PubMed |
| The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons. | Stem Cell Reports | 2024 | 38307024 | PubTator, text mining | PubMed |
| Axonal Lysosomal Assays for Characterizing the Effects of LRRK2 G2019S. | Biology (Basel) | 2024 | 38275734 | PubTator, text mining | PubMed |
| Hsa_circ_0092856 Promoted the Proliferation, Migration, and Invasion of NSCLC Cells by Up-Regulating the Expression of eIF3a. | Biomedicines | 2024 | 38275418 | PubTator, text mining | PubMed |
| Coronavirus M Protein Trafficking in Epithelial Cells Utilizes a Myosin Vb Splice Variant and Rab10. | Cells | 2024 | 38247817 | PubTator, text mining | PubMed |
| ATG14 targets lipid droplets and acts as an autophagic receptor for syntaxin18-regulated lipid droplet turnover. | Nat Commun | 2024 | 38245527 | PubTator, text mining | PubMed |
| The peroxisome: an update on mysteries 3.0. | Histochem Cell Biol | 2024 | 38244103 | PubTator, text mining | PubMed |
| LncRNA PSMB8-AS1 increases glioma malignancy via the miR-382-3p/BCAT1 axis. | Transl Oncol | 2024 | 38235619 | PubTator, text mining | PubMed |
| The V-ATPase-ATG16L1 axis recruits LRRK2 to facilitate the lysosomal stress response. | J Cell Biol | 2024 | 38227290 | PubTator, text mining | PubMed |
| Analyzing secretory proteins in human dermal fibroblast-conditioned medium for angiogenesis: A bioinformatic approach. | Skin Res Technol | 2024 | 38200622 | PubTator, text mining | PubMed |
| The selection landscape and genetic legacy of ancient Eurasians. | Nature | 2024 | 38200293 | PubTator, text mining | PubMed |
| A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells. | NPJ Parkinsons Dis | 2024 | 38191886 | PubTator, text mining | PubMed |
| Multi-ancestry genome-wide association meta-analysis of Parkinson's disease. | Nat Genet | 2024 | 38155330 | PubTator, text mining | PubMed |
| Targeting Rab-RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's disease. | J Pept Sci | 2024 | 38135900 | PubTator, text mining | PubMed |
| Akt may associate with insulin-responsive vesicles via interaction with sortilin. | FEBS Lett | 2024 | 38105115 | PubTator, text mining | PubMed |
| Post-translational modification and mitochondrial function in Parkinson's disease. | Front Mol Neurosci | 2023 | 38273938 | PubTator, text mining | PubMed |
| The Regulation of Exosome Generation and Function in Physiological and Pathological Processes. | Int J Mol Sci | 2023 | 38203424 | PubTator, text mining | PubMed |
| Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2. | Cells | 2023 | 38201257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10890/papers?page=6